BKK: NAM Statistics

Total Valuation

Namwiwat Medical Corporation PCL has a market cap or net worth of THB 3.19 billion. The enterprise value is 2.45 billion.

Market Cap	3.19B
Enterprise Value	2.45B

Important Dates

The next estimated earnings date is Thursday, February 27, 2025.

Earnings Date	Feb 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Namwiwat Medical Corporation PCL has 700.00 million shares outstanding. The number of shares has increased by 215.07% in one year.

Current Share Class	n/a
Shares Outstanding	700.00M
Shares Change (YoY)	+215.07%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	59.17%
Owned by Institutions (%)	1.71%
Float	93.07M

Valuation Ratios

The trailing PE ratio is 18.14.

PE Ratio	18.14
Forward PE	n/a
PS Ratio	3.28
PB Ratio	1.58
P/TBV Ratio	1.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.50, with an EV/FCF ratio of -159.77.

EV / Earnings	14.03
EV / Sales	2.54
EV / EBITDA	10.50
EV / EBIT	11.80
EV / FCF	-159.77

Financial Position

The company has a current ratio of 5.09, with a Debt / Equity ratio of 0.12.

Current Ratio	5.09
Quick Ratio	3.89
Debt / Equity	0.12
Debt / EBITDA	1.03
Debt / FCF	-15.69
Interest Coverage	15.39

Financial Efficiency

Return on equity (ROE) is 11.02% and return on invested capital (ROIC) is 6.91%.

Return on Equity (ROE)	11.02%
Return on Assets (ROA)	6.30%
Return on Invested Capital (ROIC)	6.91%
Return on Capital Employed (ROCE)	9.86%
Revenue Per Employee	2.38M
Profits Per Employee	429,382
Employee Count	406
Asset Turnover	0.47
Inventory Turnover	1.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.74% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-22.74%
50-Day Moving Average	4.53
200-Day Moving Average	4.69
Relative Strength Index (RSI)	53.81
Average Volume (20 Days)	141,511

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Namwiwat Medical Corporation PCL had revenue of THB 964.48 million and earned 174.33 million in profits. Earnings per share was 0.25.

Revenue	964.48M
Gross Profit	443.91M
Operating Income	207.19M
Pretax Income	219.33M
Net Income	174.33M
EBITDA	228.70M
EBIT	207.19M
Earnings Per Share (EPS)	0.25

Full Income Statement

Balance Sheet

The company has 998.82 million in cash and 240.08 million in debt, giving a net cash position of 758.74 million or 1.08 per share.

Cash & Cash Equivalents	998.82M
Total Debt	240.08M
Net Cash	758.74M
Net Cash Per Share	1.08
Equity (Book Value)	2.04B
Book Value Per Share	2.89
Working Capital	1.54B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 37.13 million and capital expenditures -52.44 million, giving a free cash flow of -15.31 million.

Operating Cash Flow	37.13M
Capital Expenditures	-52.44M
Free Cash Flow	-15.31M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 46.03%, with operating and profit margins of 21.48% and 18.07%.

Gross Margin	46.03%
Operating Margin	21.48%
Pretax Margin	22.74%
Profit Margin	18.07%
EBITDA Margin	23.71%
EBIT Margin	21.48%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.09, which amounts to a dividend yield of 1.97%.

Dividend Per Share	0.09
Dividend Yield	1.97%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	36.13%
Buyback Yield	-215.07%
Shareholder Yield	-213.10%
Earnings Yield	5.46%
FCF Yield	-0.48%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Namwiwat Medical Corporation PCL has an Altman Z-Score of 6.61.

Altman Z-Score	6.61
Piotroski F-Score	n/a